Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Measurements using the alkaline comet assay predict bladder cancer cell radiosensitivity.

M A L Moneef1, B T Sherwood, K J Bowman

  • 1Department of Cancer Studies and Molecular Medicine, Hodgkin Building, University of Leicester, Lancaster Road, PO Box 138, Leicester LE1 9HN, UK.

British Journal of Cancer
|December 17, 2003
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prediction models of adverse outcomes following surgery and radiotherapy for breast cancer: a systematic review.

ESMO real world data and digital oncology·2026
Same author

Novel Radiobiology is an Essential Pillar for the Future of Radiation Oncology.

Clinical oncology (Royal College of Radiologists (Great Britain))·2021
Same author

FLASH Radiotherapy: A Clarification.

Clinical oncology (Royal College of Radiologists (Great Britain))·2020
Same author

Personal View: Learning Healthcare System for Radiotherapy - Maximising the Opportunities and Minimising the Threats.

Clinical oncology (Royal College of Radiologists (Great Britain))·2020
Same author

FLASH Radiotherapy: The Next Technological Advance in Radiation Therapy?

Clinical oncology (Royal College of Radiologists (Great Britain))·2019
Same author

Hot Topics in Radiobiology.

Clinical oncology (Royal College of Radiologists (Great Britain))·2019

Predicting bladder cancer radiosensitivity is key for effective treatment. The alkaline comet assay (ACA) accurately measures DNA damage, correlating strongly with cell killing and predicting patient response to radiotherapy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Radiotherapy Research

Background:

  • Invasive bladder cancer treatment in the UK relies on radiotherapy or cystectomy.
  • Radiotherapy response rates are suboptimal, with approximately 50% of patients not responding.
  • Predicting tumour radiosensitivity could personalize treatment and improve outcomes.

Purpose of the Study:

  • To evaluate the alkaline comet assay (ACA) as a predictive tool for bladder cancer radiosensitivity.
  • To correlate DNA damage assessed by ACA with cell survival following radiation exposure.
  • To assess the potential clinical application of ACA in bladder cancer treatment selection.

Main Methods:

  • Utilized six human bladder cancer cell lines with varying radiosensitivities.

Related Experiment Videos

  • Assessed radiogenic DNA damage using the alkaline comet assay (ACA).
  • Compared comet formation and residual DNA damage with cell survival and radiosensitivity.

    • Main Results:

    • Strong correlation (R2>0.96) observed between comet formation extent and cancer cell killing.
    • Radiosensitive cell lines exhibited a greater response in the ACA.
    • Residual DNA damage correlated with survival fraction at 2 Gy in most cell lines.
    • ACA predicted a wide range of radiosensitivities in human bladder tumour biopsy samples.

    Conclusions:

    • The alkaline comet assay (ACA) is a reliable predictor of bladder cancer cell radiosensitivity at low radiation doses.
    • ACA demonstrates potential for clinical application in guiding bladder cancer treatment decisions.
    • Personalized radiotherapy selection based on ACA results could improve treatment efficacy.